{"DataElement":{"publicId":"6968133","version":"1","preferredName":"Bladder Carcinoma Decipher Cancer Assay Molecular Subtype Classification Type","preferredDefinition":"The response that indicates the molecular subtype of bladder carcinoma determined using a Decipher Bladder Assay.","longName":"BLD_CRCN_ML_STYP_TYP","context":"DCI","contextVersion":"1","DataElementConcept":{"publicId":"6968132","version":"1","preferredName":"Bladder Carcinoma Decipher Cancer Assay Molecular Subtype Classification","preferredDefinition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas._A genomic subtyping tool designed to identify muscle invasive bladder cancer patients who may benefit from neoadjuvant chemotherapy prior to surgery._Relating to or produced by or consisting of molecules._A group forming a type within a larger type._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"3135356v1.0:6968130v1.0","context":"DCI","contextVersion":"1","ObjectClass":{"publicId":"3135356","version":"1","preferredName":"Bladder Carcinoma","preferredDefinition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.","longName":"C4912","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Carcinoma","conceptCode":"C4912","definition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FC1173C-8ADA-5FB1-E040-BB89AD432078","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6968130","version":"1","preferredName":"Decipher Bladder Cancer Assay Molecular Subtype Classification","preferredDefinition":"A genomic subtyping tool designed to identify muscle invasive bladder cancer patients who may benefit from neoadjuvant chemotherapy prior to surgery.:Relating to or produced by or consisting of molecules.:A group forming a type within a larger type.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"C165251:C25574:C25696:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Decipher Bladder Cancer Assay","conceptCode":"C165251","definition":"A genomic subtyping tool designed to identify muscle invasive bladder cancer patients who may benefit from neoadjuvant chemotherapy prior to surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Molecular","conceptCode":"C25574","definition":"Relating to or produced by or consisting of molecules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9418F8F1-4DB8-2BC3-E053-F662850A5F86","latestVersionIndicator":"Yes","beginDate":"2019-10-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-04","modifiedBy":"ONEDATA","dateModified":"2019-10-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9418F8F1-4DC9-2BC3-E053-F662850A5F86","latestVersionIndicator":"Yes","beginDate":"2019-10-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-04","modifiedBy":"HARTLEYG","dateModified":"2019-10-04","changeDescription":"Curated to support GU_TRIO_BLADDER_102352","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6961715","version":"1","preferredName":"Bladder Carcinoma Molecular Subtype Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"BLD_CRCN_MOL_STP_TYP","context":"DCI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Basal","valueDescription":"Basal Cell Carcinoma","ValueMeaning":{"publicId":"6796707","version":"1","preferredName":"Basal Cell Carcinoma","longName":"6796707","preferredDefinition":"A carcinoma involving the basal cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Basal Cell Carcinoma","conceptCode":"C156767","definition":"A carcinoma involving the basal cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C5201B3-6FFD-5291-E053-F662850A82DE","latestVersionIndicator":"Yes","beginDate":"2019-06-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-27","modifiedBy":"ONEDATA","dateModified":"2019-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93F507E5-378F-7B1E-E053-F662850A9E56","beginDate":"2019-10-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","deletedIndicator":"No"},{"value":"Basal Claudin-Low","valueDescription":"Basal Cell Carcinoma Claudin-Low","ValueMeaning":{"publicId":"6961716","version":"1","preferredName":"Basal Cell Carcinoma Claudin-Low","longName":"6961716","preferredDefinition":"A carcinoma involving the basal cells.: A genetic profile indicating low expression of cellular tight junction proteins, including E-cadherin, which is often associated with triple-negative breast cancer and tumor-infiltrating lymphocytes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Basal Cell Carcinoma","conceptCode":"C156767","definition":"A carcinoma involving the basal cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Claudin-Low","conceptCode":"C105907","definition":"A genetic profile indicating low expression of cellular tight junction proteins, including E-cadherin, which is often associated with triple-negative breast cancer and tumor-infiltrating lymphocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93F507E5-3762-7B1E-E053-F662850A9E56","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93F507E5-377B-7B1E-E053-F662850A9E56","beginDate":"2019-10-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","deletedIndicator":"No"},{"value":"Luminal infiltrated","valueDescription":"Luminal Cellular Infiltrate","ValueMeaning":{"publicId":"6961717","version":"1","preferredName":"Luminal Cellular Infiltrate","longName":"6961717","preferredDefinition":"Relating to the lumen of a blood vessel or other tubular structure.: An influx of cells, generally leukocytes, in locations or numbers not normally found, without other features of inflammation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Luminal","conceptCode":"C26456","definition":"Relating to the lumen of a blood vessel or other tubular structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cellular Infiltrate","conceptCode":"C42077","definition":"An influx of cells, generally leukocytes, in locations or numbers not normally found, without other features of inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93F507E5-379D-7B1E-E053-F662850A9E56","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93F507E5-37B6-7B1E-E053-F662850A9E56","beginDate":"2019-10-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","deletedIndicator":"No"},{"value":"Luminal","valueDescription":"Luminal","ValueMeaning":{"publicId":"6961718","version":"1","preferredName":"Luminal","longName":"6961718","preferredDefinition":"Relating to the lumen of a blood vessel or other tubular structure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Luminal","conceptCode":"C26456","definition":"Relating to the lumen of a blood vessel or other tubular structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93F507E5-37C2-7B1E-E053-F662850A9E56","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93F507E5-37DB-7B1E-E053-F662850A9E56","beginDate":"2019-10-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93F507E5-3749-7B1E-E053-F662850A9E56","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-02","modifiedBy":"HARTLEYG","dateModified":"2019-10-04","changeDescription":"Curated to support Protocol GU_TRIOBLADDER_102352","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What is the subtype classifie","type":"Preferred Question Text","description":"What is the subtype classified from Decipher Bladder Assay","url":null,"context":"DCI"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94190C73-A042-431B-E053-F662850AF46A","latestVersionIndicator":"Yes","beginDate":"2019-10-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-04","modifiedBy":"HARTLEYG","dateModified":"2019-10-04","changeDescription":"Curated to support GU_TRIO_BLADDER_102352","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}